A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)

Clinical trial NCT06136598 · COMPLETED

Trial details

NCT number: NCT06136598
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms Metastatic Castration-Resistant Prostate Cancer

Start date: 2024-01-30
Primary completion: 2026-03-09
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.